| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Revenue | $34.86B | +11.2% |
| Cost of Revenue | $8.54B | +2.2% |
| Gross Profit | $26.32B | +14.5% |
| R&D Expense | $4.91B | -2.9% |
| SG&A Expense | $2.53B | -0.7% |
| Operating Income | $5.01B | +386.5% |
| Pre-tax Income | $4.95B | +650.0% |
| Income Tax | $814.0M | +80.1% |
| Net Income | $4.14B |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $8.47B | +20.8% |
| Accounts Receivable | $11.41B | +6.1% |
| Current Assets | $29.07B | +10.1% |
| Total Assets | $99.82B | +1.0% |
| Current Liabilities | $26.63B | +2.9% |
| Long-term Debt | $9.43B | -11.1% |
| Total Liabilities | $40.18B | -0.8% |
| Line Item | 2024-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $10.23B | +43.9% |
| Capital Expenditures | $736.0M | -7.8% |
| Investing Cash Flow | -$1.33B | +33.3% |
| Financing Cash Flow | -$7.48B | -109.9% |
| Free Cash Flow | $9.50B | +50.5% |
| +1888.5% |
| EPS (Basic) | $4.25 | +1923.8% |
| EPS (Diluted) | $4.20 | +1900.0% |
| Stockholders' Equity |
| $59.65B |
| +2.2% |